Company Filing History:
Years Active: 2014
Title: Innovations by Elizabeth E Brittle in Herpes Simplex Virus Vaccines
Introduction
Elizabeth E Brittle is a notable inventor based in Middletown, MD (US). She has made significant contributions to the field of medical research, particularly in the development of vaccines for Herpes Simplex Virus (HSV) infections. Her work aims to improve the treatment and management of HSV, which affects millions of individuals worldwide.
Latest Patents
Elizabeth E Brittle holds 1 patent related to HSV-1 and HSV-2 vaccines and methods of use thereof. This invention provides methods for treating, suppressing, inhibiting, and reducing the incidence of primary or recurring HSV infections. It also addresses the pathogenesis of HSV and associated symptoms. The innovative approach involves inducing an anti-HSV immune response in subjects through a composition that includes a mutant HSV strain with an inactivating mutation in a Us8 gene.
Career Highlights
Elizabeth is affiliated with the University of Pennsylvania, where she continues her research and development efforts. Her work has the potential to significantly impact the lives of those affected by HSV, providing new avenues for treatment and prevention.
Collaborations
She has collaborated with esteemed colleagues, including Harvey M Friedman and Fushan Wang, to advance her research and enhance the effectiveness of her inventions.
Conclusion
Elizabeth E Brittle's innovative work in the field of HSV vaccines exemplifies the importance of research in combating viral infections. Her contributions are paving the way for improved health outcomes for individuals affected by HSV.